abstract |
The invention provides a transient receptor potential vanilline (TRPV) modifier having a structure represented by formula (I). The above compounds can be used for treating or preventing TRPV3 adjusted diseases, illnesses and/or obstacles. The invention also provides preparation methods of the compounds, intermediates used in the synthesis of the compounds, pharmaceutical compositions of the compounds, and a method for treating or preventing the TRPV3 adjusted diseases, illnesses and/or obstacles. |